Characteristics of COPD patients initiating budesonide/glycopyrronium/formoterol (BGF) and other triple therapy in Japan: a health-care claims-based real-world database study (MITOS program)

Conclusions: The proportion of asthma+COPD patients was high among those initiating TT, especially MITT. Patients using BGF in the first 12 months after market approval had a higher history of exacerbations.

Source: European Respiratory Journal - October 27, 2023 Category: Respiratory Medicine Authors: Takahashi, K., Makita, N., Castaneda, J., Argoubi, R., Nowacki, G., Issa, S., Matsumoto, I., Yoshida, Y., Mullerova, H. Tags: Airway pharmacology and treatment Source Type: research